New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 4, 2013
15:33 EDTMDXGMiMedx reiterates FY14 revenue view $90M-$110M, consensus $99.8M
Revenues from the company's injectable are projected to be approximately 15% of the company's 2014 revenues.
News For MDXG From The Last 14 Days
Check below for free stories on MDXG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
16:23 EDTMDXGMiMedx sees operating profit for Q3, consensus 0c
Sees Q3 revenue $30M-$32M, consensus $27.45M.
16:22 EDTMDXGMiMedx raises FY14 revenue view to $110M-$115M from $105M-$110M
Subscribe for More Information
16:21 EDTMDXGMiMedx reports Q2 EPS 0c, consensus 0c
Subscribe for More Information
July 23, 2014
08:02 EDTMDXGMiMedx files its initial investigational New Drug Application
Subscribe for More Information
July 15, 2014
10:00 EDTMDXGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:57 EDTMDXGMiMedx initiated with a Buy at Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use